Fortis Advisors, LLC Mannkind Corp Transaction History

Fortis Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$1.01 - $2.19 $57,485 - $124,646	-56,916 Closed	0 $0
Q1 2018 May 11, 2018	SELL	$2.28 - $3.8 $56,999 - $95,000	-25,000 Reduced 30.52%	56,916 $130,000
Q4 2017 Feb 14, 2018	BUY	$2.28 - $6.71 $5,405 - $15,909	2,371 Added 2.98%	81,916 $190,000
Q3 2017 Nov 14, 2017	BUY	$1.15 - $2.29 $91,476 - $182,158	79,545	79,545 $173,000

248

148M

1.62M

802K

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.44B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

Get notified when there are updates to the investment portfolio of Fortis Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Fortis Advisors, LLC with notifications on news.